Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07678580 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07678580
- Sponsor
- Tang-Du Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-10
- Primary completion
- 2028-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.